218 results
8-K
EX-99.2
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
commercialize their products or support growth of such products; there may be a reduction in payment rate or reimbursement for the Company’s products
8-K
EX-99.1
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
revenue growth from such products; there may be a reduction in payment rate or reimbursement for the company’s products or an increase in the company’s
8-K
EX-10.1
ALKS
Alkermes plc
31 May 24
Departure of Directors or Certain Officers
4:05pm
be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation
8-K
EX-99.2
6rb3qgpqa2m49
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
8-K
EX-99.1
a5mu44wcd39ssg8sy29s
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
8-K
EX-99.1
wy0qnaywv0xflnxpf0rd
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
nprci 4szi
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
94pdrkom
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
pzw ik8rj0
14 Dec 23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
6:13am